[{"indications": "Indications\u00a0tinea pedis; resistant fungal infections\r\n(section 5.2.5)", "name": "GRISEOFULVIN - ANTIFUNGAL PREPARATIONS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.10 Anti-infective skin preparations", "13.10.2 Antifungal preparations"], "cautions": "Cautions\u00a0\n(From 13.10.2 Antifungal preparations: British National Formulary)\nCautions\u00a0Contact with eyes and mucous membranes should be avoided.", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129234.htm", "doses": ["Apply 400\u00a0micrograms (1 spray) to an area approx. 13\u00a0cm2 once daily, increased to 1.2\u00a0mg (3 sprays, allowing each\r\nspray to dry between applications) once daily if necessary; max. treatment\r\nduration 4 weeks"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk"}, {"indications": "Indications\u00a0dermatophyte infections of the skin, scalp, hair and nails where\r\ntopical therapy has failed or is inappropriate", "name": "GRISEOFULVIN - OTHER ANTIFUNGALS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.2 Antifungal drugs", "5.2.5 Other antifungals", "GRISEOFULVIN"], "cautions": "Cautions\u00a0interactions: Appendix 1 (griseofulvin)Driving\u00a0May impair performance of\r\nskilled tasks (e.g. driving); effects of alcohol enhanced", "side-effects": "Side-effects\u00a0nausea, vomiting, diarrhoea; headache; also reported,\r\nabdominal pain, dyspepsia, hepatotoxicity, glossitis, taste disturbances,\r\nsleep disturbances, dizziness, fatigue, confusion, agitation, depression,\r\nimpaired coordination and hearing, peripheral neuropathy,\r\nmenstrual disturbances, renal failure, leucopenia, systemic lupus\r\nerythematosus, rash (including rarely erythema multiforme, toxic epidermal\r\nnecrolysis), and photosensitivity", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/208054.htm", "doses": ["Dermatophyte infections, 500\u00a0mg once daily or in\r\ndivided doses; in severe infection dose may be doubled, reducing when\r\nresponse occurs; child under 50\u00a0kg,\r\n10\u00a0mg/kg once daily or in divided doses", "Tinea capitis caused by Trichophyton tonsurans, 1\u00a0g once daily or in divided doses; child under 50\u00a0kg, 15\u201320\u00a0mg/kg once daily or in divided doses", "Griseofulvin doses in BNF may differ from\r\nthose in product literature"], "pregnancy": "Pregnancy\u00a0avoid (fetotoxicity and teratogenicity in animals); effective contraception required during and for\r\nat least 1 month after administration to women (important: effectiveness of oral contraceptives may be reduced, additional\r\ncontraceptive precautions e.g. barrier method, required); also men\r\nshould avoid fathering a child during and for at least 6 months after\r\nadministration"}, {"indications": "Indications\u00a0tinea pedis; resistant fungal infections\r\n(section 5.2.5)", "name": "GRISEOFULVIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.10 Anti-infective skin preparations", "13.10.2 Antifungal preparations"], "cautions": "Cautions\u00a0\n(From 13.10.2 Antifungal preparations: British National Formulary)\nCautions\u00a0Contact with eyes and mucous membranes should be avoided.", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129234.htm", "doses": ["Apply 400\u00a0micrograms (1 spray) to an area approx. 13\u00a0cm2 once daily, increased to 1.2\u00a0mg (3 sprays, allowing each\r\nspray to dry between applications) once daily if necessary; max. treatment\r\nduration 4 weeks"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk"}]